Inactive Instrument
Cell MedX Corp Stock OTC Bulletin Board
Stocks
US15115X1072
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 4.65M 4.08M 3.84M 3.51M 6.56M 446M 6.6M 46.09M 17.87M 227M 17.47M 17.08M 736M | P/E 2027 * |
-11x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 4.65M 4.08M 3.84M 3.51M 6.56M 446M 6.6M 46.09M 17.87M 227M 17.47M 17.08M 736M | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 7.75x |
| Free-Float |
28.33% | Yield 2027 * |
-
| Yield 2028 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 56 | 12/12/2023 |
Yanika Silina
DFI | Director of Finance/CFO | 48 | 24/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
George Adams
CHM | Chairman | 74 | 26/02/2024 |
Joao da Costa
BRD | Director/Board Member | 62 | 08/06/2020 |
David Jeffs
BRD | Director/Board Member | 56 | 12/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.50% | +3.52% | +7.55% | +30.57% | 47.56B | ||
| -0.83% | -0.36% | +43.66% | +34.77% | 44.09B | ||
| -0.84% | +4.86% | +10.92% | +91.52% | 41.5B | ||
| -1.10% | -2.64% | +331.49% | +535.80% | 40.88B | ||
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | ||
| -2.07% | +0.12% | +24.39% | +154.30% | 17.23B | ||
| +0.42% | -0.60% | +23.46% | +39.61% | 15.06B | ||
| -6.08% | -9.92% | - | - | 14.65B | ||
| -0.78% | +9.46% | -8.96% | - | 13.82B | ||
| Average | -1.16% | +0.69% | +54.20% | +133.23% | 29.39B | |
| Weighted average by Cap. | -0.75% | +0.96% | +67.94% | +141.15% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 600K 527K 495K 453K 846K 57.47M 852K 5.95M 2.31M 29.3M 2.25M 2.2M 95.01M |
| Net income | -510K -448K -421K -385K -719K -48.85M -724K -5.05M -1.96M -24.91M -1.92M -1.87M -80.76M | - |
| Net Debt | - | - |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















